Anixa Biosciences, Inc. (ANIX)

Trade ANIX now with
8/15/2022 8:31:44 AM Anixa Biosciences Announces Treatment Of First Patient In Its Ovarian Cancer CAR-T Clinical Trial
7/21/2022 8:36:41 AM Anixa Announces Notice Of Allowance Of Addl Patent On Breast Cancer Vaccine Technology
6/21/2022 8:40:15 AM Anixa : Data Shows Formulation Of AMHR2-ED Vaccine With AddaVax Adjuvant Induced High Serum Titers Of Immunoglobulin G
1/25/2022 8:46:48 AM Anixa Biosciences Reports Japanese Patent On Ovarian Cancer Vaccine
12/7/2021 8:39:03 AM Anixa Biosciences, MolGenie COVID-19 Compounds Expected To Be Effective Against Omicron Variant
10/26/2021 8:36:51 AM Anixa Announces Patient Dosing Of Its Vaccine Candidate In First-of-its-Kind Preventative Breast Cancer Vaccine Study
10/6/2021 8:31:44 AM Anixa Biosciences Reports First Chinese Patent On Its CAR-T Cancer Therapy Technology
10/1/2021 8:31:47 AM Anixa Announces Notice Of Allowance For Additional Patent On CAR-T Cancer Therapy
8/30/2021 8:33:45 AM Anixa And Moffitt Cancer Center Announce FDA Clearance To Initiate Clinical Trial Of Ovarian Cancer CAR-T Immunotherapy
8/25/2021 8:38:26 AM Anixa Biosciences' Covid-19 Compounds Expected To Be Effective Against Delta Variant; Stock Up